Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-07

FDA Approved: MESALAMINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mesalamine (Actavis Pharma, Inc.), allowing continued marketing of Mesalamine products.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)